newest glp-1 medications for type 2 diabetes 2025 Impact: How GLP-1s Are Changing the Treatment Paradigm Beyond GLP-1: the next wave

There have been reports that iris darkening is a side effect of using these types of products, though that was never their intended purpose

Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study

Monitoring: Because long-term data are sparse, ongoing follow-up is wise

If switching from the pill to injectable, the injection will be administered the day after stopping the pill

The healing of the skin and colon defect, as colocutaneous fistulas, stable gastric pentadecapeptide BPC 157, and the therapy regimens (per-oral, in drinking water

For weight management, only semaglutide (Wegovy) and liraglutide (Saxenda) are specifically licensed in the UK, with access typically through specialist weight management services according to NICE criteria